- Home
- PHGE vs SOWG Comparison
PHGE vs SOWG Comparison
Compare PHGE & SOWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- SOWG
- Stock Information
- Founded
- PHGE 2015
- SOWG 2010
- Country
- PHGE Israel
- SOWG United States
- Employees
- PHGE N/A
- SOWG 86
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- SOWG Packaged Foods
- Sector
- PHGE Health Care
- SOWG Consumer Staples
- Exchange
- PHGE Nasdaq
- SOWG Nasdaq
- Market Cap
- PHGE 10.4M
- SOWG 10.7M
- IPO Year
- PHGE N/A
- SOWG N/A
- Fundamental
- Price
- PHGE $0.56
- SOWG $0.72
- Analyst Decision
- PHGE Strong Buy
- SOWG
- Analyst Count
- PHGE 1
- SOWG 0
- Target Price
- PHGE $15.00
- SOWG N/A
- AVG Volume (30 Days)
- PHGE 12.4M
- SOWG 4.5M
- Earning Date
- PHGE 08-13-2025
- SOWG 08-14-2025
- Dividend Yield
- PHGE N/A
- SOWG N/A
- EPS Growth
- PHGE N/A
- SOWG N/A
- EPS
- PHGE N/A
- SOWG N/A
- Revenue
- PHGE N/A
- SOWG $9,271,376.00
- Revenue This Year
- PHGE N/A
- SOWG $6.81
- Revenue Next Year
- PHGE N/A
- SOWG N/A
- P/E Ratio
- PHGE N/A
- SOWG N/A
- Revenue Growth
- PHGE N/A
- SOWG N/A
- 52 Week Low
- PHGE $0.34
- SOWG $0.52
- 52 Week High
- PHGE $1.90
- SOWG $18.91
- Technical
- Relative Strength Index (RSI)
- PHGE 57.85
- SOWG 41.12
- Support Level
- PHGE $0.48
- SOWG $0.64
- Resistance Level
- PHGE $0.59
- SOWG $1.05
- Average True Range (ATR)
- PHGE 0.07
- SOWG 0.14
- MACD
- PHGE 0.01
- SOWG -0.02
- Stochastic Oscillator
- PHGE 52.48
- SOWG 14.64
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About SOWG Sow Good Inc. Common Stock
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.